FIVE PRIME THERAPEUTICS INC's ticker is FPRX and the CUSIP is 33830X104.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $14,701,000 | +734950.0% | 864,288 | +215972.0% | 0.00% | – |
Q3 2020 | $2,000 | -33.3% | 400 | -68.0% | 0.00% | – |
Q1 2020 | $3,000 | +50.0% | 1,250 | +150.0% | 0.00% | – |
Q4 2019 | $2,000 | -99.8% | 500 | -99.8% | 0.00% | – |
Q3 2019 | $1,170,000 | -89.3% | 302,012 | -83.3% | 0.00% | -100.0% |
Q2 2019 | $10,906,000 | -78.0% | 1,808,684 | -51.1% | 0.00% | -83.3% |
Q1 2019 | $49,568,000 | +43.8% | 3,699,068 | -0.2% | 0.01% | +20.0% |
Q4 2018 | $34,482,000 | -38.6% | 3,707,768 | -8.1% | 0.01% | -16.7% |
Q3 2018 | $56,185,000 | -32.7% | 4,036,313 | -23.6% | 0.01% | -40.0% |
Q2 2018 | $83,498,000 | -7.1% | 5,281,363 | +1.0% | 0.01% | -9.1% |
Q1 2018 | $89,835,000 | -5.6% | 5,229,044 | +20.5% | 0.01% | 0.0% |
Q4 2017 | $95,122,000 | -46.4% | 4,339,506 | +0.1% | 0.01% | -47.6% |
Q3 2017 | $177,356,000 | +36.4% | 4,335,266 | +0.4% | 0.02% | +31.2% |
Q2 2017 | $130,010,000 | -17.2% | 4,317,819 | -0.6% | 0.02% | -20.0% |
Q1 2017 | $157,017,000 | -26.6% | 4,343,501 | +1.8% | 0.02% | -31.0% |
Q4 2016 | $213,776,000 | -4.2% | 4,266,120 | +0.3% | 0.03% | -3.3% |
Q3 2016 | $223,160,000 | +91.6% | 4,251,478 | +50.9% | 0.03% | +87.5% |
Q2 2016 | $116,492,000 | +26.3% | 2,817,208 | +24.1% | 0.02% | +23.1% |
Q1 2016 | $92,206,000 | – | 2,269,400 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|